SUD Half Yearly Report and Accounts |
28/02/19 | PRICE SENSITIVE | | Share |
|
SUD Appendix 4C Amended |
04/02/19 | PRICE SENSITIVE | | Share |
|
SUD Appendix 4C - quarterly |
31/01/19 | PRICE SENSITIVE | | Share |
|
SUD SUDA Signs Agreement With Mitsubishi Tanabe |
19/12/18 | PRICE SENSITIVE | | Share |
|
SUD ZLD: ZLD to Invest in Development of Oral Spray Formulations |
06/12/18 | PRICE SENSITIVE | | Share |
|
SUD SUDA Enters Agreement To Develop Cannabinoid Spray |
06/12/18 | PRICE SENSITIVE | | Share |
|
SUD SUDA Receives R&D Tax Incentive Refund |
15/11/18 | PRICE SENSITIVE | | Share |
|
SUD ZolpiMist Market Update |
13/11/18 | PRICE SENSITIVE | | Share |
|
SUD SUDA Signs Agreement For SUD-001H For US Market |
08/11/18 | PRICE SENSITIVE | | Share |
|
SUD Trading Halt |
07/11/18 | PRICE SENSITIVE | | Share |
|
SUD Appendix 4C, Market Update and Top 20 |
29/10/18 | PRICE SENSITIVE | | Share |
|
SUD Reinstatement to Official Quotation |
17/10/18 | PRICE SENSITIVE | | Share |
|
SUD Response to ASX Price Query |
17/10/18 | PRICE SENSITIVE | | Share |
|
SUD Suspension from Official Quotation |
17/10/18 | PRICE SENSITIVE | | Share |
|
SUD Pause in Trading |
17/10/18 | PRICE SENSITIVE | | Share |
|
SUD Market Update |
12/09/18 | PRICE SENSITIVE | | Share |
|
SUD Request for Trading Halt |
11/09/18 | PRICE SENSITIVE | | Share |
|
SUD Trading Halt |
11/09/18 | PRICE SENSITIVE | | Share |
|
SUD Pause in Trading |
11/09/18 | PRICE SENSITIVE | | Share |
|
SUD Preliminary Final Report |
31/08/18 | PRICE SENSITIVE | | Share |
|
SUD SUDA Achieves TGA GMP Licence |
21/08/18 | PRICE SENSITIVE | | Share |
|
SUD Rights Issue Closes Significantly Oversubscribed |
31/07/18 | PRICE SENSITIVE | | Share |
|
SUD Supplementary Prospectus |
31/07/18 | PRICE SENSITIVE | | Share |
|
SUD Appendix 4C - quarterly |
31/07/18 | PRICE SENSITIVE | | Share |
|
SUD Business Development Update |
16/07/18 | PRICE SENSITIVE | 147.27KB | Share |
|
SUD Anagrelide Update |
12/07/18 | PRICE SENSITIVE | 648.78KB | Share |
|
SUD Prospectus for a Renounceable Pro Rata Offer |
02/07/18 | PRICE SENSITIVE | 1.34MB | Share |
|
SUD Settlement with HC Berlin Pharma and Rights Issue |
02/07/18 | PRICE SENSITIVE | 196.79KB | Share |
|
SUD Trading Halt |
28/06/18 | PRICE SENSITIVE | 149.12KB | Share |
|
SUD Shareholder Update |
21/06/18 | PRICE SENSITIVE | 169.11KB | Share |
|
SUD SUDA Expands Patent Coverage For Sildenafil |
18/06/18 | PRICE SENSITIVE | 141.45KB | Share |
|
SUD SUDA announces update on ZolpiMist in USA and Canada |
15/06/18 | PRICE SENSITIVE | 646.48KB | Share |
|
SUD SUDA expands dialogue with World Health Organisation |
07/05/18 | PRICE SENSITIVE | | Share |
|
SUD HC Berlin Pharma Update |
01/05/18 | PRICE SENSITIVE | | Share |
|
SUD Appendix 4C - quarterly |
30/04/18 | PRICE SENSITIVE | | Share |
|
SUD HC Berlin Pharma Update |
29/03/18 | PRICE SENSITIVE | | Share |
|
SUD SUDA Completes Divestment of Subsidiary |
08/03/18 | PRICE SENSITIVE | | Share |
|
SUD Half Yearly Report and Accounts |
28/02/18 | PRICE SENSITIVE | | Share |
|
SUD Divestment Of Non-Core Subsidiary |
27/02/18 | PRICE SENSITIVE | | Share |
|
SUD New Analyst Report |
16/02/18 | PRICE SENSITIVE | | Share |
|
SUD Appendix 4C - quarterly |
31/01/18 | PRICE SENSITIVE | | Share |
|
SUD SUDA Completes Acquisition Of Anti-Cancer Agent |
24/01/18 | PRICE SENSITIVE | | Share |
|
SUD SUDA's Licensee Submits Marketing Application |
06/12/17 | PRICE SENSITIVE | | Share |
|
SUD SUDA Receives R&D Tax Incentive Refund |
30/11/17 | PRICE SENSITIVE | | Share |
|
SUD SUDA Acquires Novel Oro-Mucosal Anti-Cancer Agent |
28/11/17 | PRICE SENSITIVE | | Share |
|
SUD Appendix 4C - quarterly |
31/10/17 | PRICE SENSITIVE | | Share |
|
SUD SUDA Publishes Amended Shareholder Newsletter |
12/09/17 | PRICE SENSITIVE | | Share |
|
SUD Preliminary Final Report |
31/08/17 | PRICE SENSITIVE | | Share |
|
SUD SUDA Achieves ISO Accreditation |
31/07/17 | PRICE SENSITIVE | | Share |
|
SUD Appendix 4C - quarterly |
27/07/17 | PRICE SENSITIVE | | Share |
|
SUD Strong Revenue Growth for SUDA Subsidiary |
24/07/17 | PRICE SENSITIVE | | Share |
|
SUD SUDA Enters Licence Agreement With Teva |
05/07/17 | PRICE SENSITIVE | | Share |
|
SUD Trading Halt |
04/07/17 | PRICE SENSITIVE | | Share |
|
SUD SUDA Signs Term Sheet To Acquire Anti-Cancer Agent |
20/06/17 | PRICE SENSITIVE | | Share |
|
SUD SUDA Meeting For Zolpimist Into Europe |
25/05/17 | PRICE SENSITIVE | | Share |
|
SUD Placement, Interest Shares and Convertible Note Prospectus |
24/04/17 | PRICE SENSITIVE | | Share |
|
SUD Appendix 4C - quarterly |
19/04/17 | PRICE SENSITIVE | | Share |
|
SUD SUDA Completes $1.5m Capital Raising |
07/04/17 | PRICE SENSITIVE | | Share |
|
SUD Trading Halt |
05/04/17 | PRICE SENSITIVE | | Share |
|
SUD SUDA Submits Application For ArTiMist |
03/04/17 | PRICE SENSITIVE | | Share |
|
SUD SUDA Extends Maturity of Convertible Notes |
03/04/17 | PRICE SENSITIVE | | Share |
|
SUD SUDA Enters Feasibility Agreement With Pfizer |
29/03/17 | PRICE SENSITIVE | | Share |
|
SUD SUDA expands patent coverage for SUD-003 and SUD-004 |
03/03/17 | PRICE SENSITIVE | | Share |
|
SUD SUDA Announces Strong Revenue For Westcoast |
27/02/17 | PRICE SENSITIVE | | Share |
|
SUD Half Yearly Report and Accounts |
27/02/17 | PRICE SENSITIVE | | Share |
|
SUD Reinstatement to official quotation |
27/02/17 | PRICE SENSITIVE | | Share |
|
SUD SUDA Update On Discussions with Berlin Pharma |
27/02/17 | PRICE SENSITIVE | | Share |
|
SUD Suspension from official quotation |
27/01/17 | PRICE SENSITIVE | | Share |
|
SUD Trading Halt |
24/01/17 | PRICE SENSITIVE | | Share |
|
SUD SUDA presents data on novel technology |
17/11/16 | PRICE SENSITIVE | | Share |
|
SUD SUDA Enters Licensing Agreement For ZolpiMist in China |
09/11/16 | PRICE SENSITIVE | | Share |
|
SUD Technology patent application-SUD.AX |
02/11/16 | PRICE SENSITIVE | | Share |
|
SUD Appendix 4C - quarterly-SUD.AX |
31/10/16 | PRICE SENSITIVE | | Share |
|
SUD Preliminary Final Report-SUD.AX |
31/08/16 | PRICE SENSITIVE | | Share |
|
SUD Appendix 4C - quarterly-SUD.AX |
29/07/16 | PRICE SENSITIVE | | Share |
|
SUD Update on HC Berlin Pharma-SUD.AX |
03/06/16 | PRICE SENSITIVE | | Share |
|
SUD Appendix 4C - quarterly-SUD.AX |
29/04/16 | PRICE SENSITIVE | | Share |
|
SUD Business development update-SUD.AX |
19/04/16 | PRICE SENSITIVE | | Share |
|
SUD SUDA granted Canadian Patent for SUD-002-SUD.AX |
12/04/16 | PRICE SENSITIVE | | Share |
|
SUD Half Yearly Report and Accounts (including Appendix 4D) |
26/02/16 | PRICE SENSITIVE | | Share |
|
SUD SUDA receives $0.7m R&D tax incentive refund |
05/02/16 | PRICE SENSITIVE | | Share |
|
SUD Appendix 4C - quarterly |
29/01/16 | PRICE SENSITIVE | | Share |
|
SUD SUDA amends agreement with Amherst Pharmaceuticals |
10/12/15 | PRICE SENSITIVE | | Share |
|
SUD Response to Price Query Letter |
07/12/15 | PRICE SENSITIVE | | Share |
|
SUD Appendix 4C - quarterly |
30/10/15 | PRICE SENSITIVE | | Share |
|
SUD SUDA allowed first USA patent for SUD-003 and SUD-004 |
08/10/15 | PRICE SENSITIVE | | Share |
|
SUD Preliminary Final Report |
31/08/15 | PRICE SENSITIVE | | Share |
|
SUD SUDA announces ArTiMist clinical publication |
27/08/15 | PRICE SENSITIVE | | Share |
|
SUD SUDA takes full control of ArTiMist |
26/08/15 | PRICE SENSITIVE | | Share |
|
SUD SUDA receives positive response from FDA regarding SUD-001 |
06/08/15 | PRICE SENSITIVE | | Share |
|
SUD SUDA granted African patent for ArTiMist |
31/07/15 | PRICE SENSITIVE | | Share |
|
SUD Appendix 4C - quarterly |
28/07/15 | PRICE SENSITIVE | | Share |
|
SUD SUDA granted US patent for SUD-002 oral spray |
27/07/15 | PRICE SENSITIVE | | Share |
|
SUD SUDA progresses business development at BIO 2015 |
29/06/15 | PRICE SENSITIVE | | Share |
|
SUD Appendix 4C - quarterly |
30/04/15 | PRICE SENSITIVE | | Share |
|
SUD SUDA announces ArTiMist peer-reviewed publications |
24/04/15 | PRICE SENSITIVE | | Share |
|
SUD Suda completes $5.3m capital raising |
27/03/15 | PRICE SENSITIVE | | Share |
|
SUD Trading Halt |
26/03/15 | PRICE SENSITIVE | | Share |
|
SUD Appendix 4D Half Year Ended 31 December 2014 |
27/02/15 | PRICE SENSITIVE | | Share |
|
SUD Suda Granted First Patent For Sildenafil In Australia |
30/01/15 | PRICE SENSITIVE | | Share |